University of California Los Angeles
- Clinical study sponsored: Pfizer Inc.
- Consultant: Lundbeck; Supernus Pharmaceuticals, Inc.; UCB; Upsher-Smith Laboratories, Inc.
- Grant Support: National Institute of Neurological Disorders and Stroke; Pfizer Inc.
- Speakers Bureau: GlaxoSmithKline